105 related articles for article (PubMed ID: 3894804)
1. Immunological detection of covert leukaemic spread in mediastinal T-cell lymphoblastic lymphoma.
Bradstock KF; Kerr A
Leuk Res; 1985; 9(7):905-11. PubMed ID: 3894804
[TBL] [Abstract][Full Text] [Related]
2. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
3. Single-cell immunofluorescence assay for terminal transferase: human leukaemic and non-leukaemic cells.
Okamura S; Crane F; Jamal N; Messner HA; Mak TW
Br J Cancer; 1980 Feb; 41(2):159-67. PubMed ID: 6989382
[TBL] [Abstract][Full Text] [Related]
4. Diversity of immunological phenotypes of lymphoblastic lymphoma.
Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
[TBL] [Abstract][Full Text] [Related]
5. [Detection of low numbers of malignant cells in patients with leukemia or non-Hodgkin lymphoma: use of immunological markers].
van Dongen JJ; Hooijkaas H; Adriaansen HJ; Hählen K; van Zanen GE
Tijdschr Kindergeneeskd; 1986 Apr; 54(2):41-5. PubMed ID: 3520946
[TBL] [Abstract][Full Text] [Related]
6. Identification of lymphoblastic lymphoma cells using a dual assay for T cell differentiation markers.
Smith RG; Galosy SJ
Cancer; 1979 Dec; 44(6):2059-64. PubMed ID: 315815
[TBL] [Abstract][Full Text] [Related]
7. Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases.
Long JC; McCaffrey RP; Aisenberg AC; Marks SM; Kung PC
Cancer; 1979 Dec; 44(6):2127-39. PubMed ID: 315816
[TBL] [Abstract][Full Text] [Related]
8. Immunofluorescent and biochemical studies of terminal deoxynucleotidyl transferase in treated acute leukaemia.
Bradstock KF; Janossy G; Hoffbrand AV; Ganeshaguru K; Llewellin P; Prentice HG; Bollum FJ
Br J Haematol; 1981 Jan; 47(1):121-31. PubMed ID: 7002202
[TBL] [Abstract][Full Text] [Related]
9. Immunologic complexity of lymphoblastic lymphoma.
Grogan T; Spier C; Wirt DP; Hicks MJ; Paquin M; Hutter J; Miller T; Rangel C; Richter L; Jones S
Diagn Immunol; 1986; 4(2):81-8. PubMed ID: 3086016
[TBL] [Abstract][Full Text] [Related]
10. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
Gore SD; Kastan MB; Goodman SN; Civin CI
J Immunol Methods; 1990 Sep; 132(2):275-86. PubMed ID: 1698878
[TBL] [Abstract][Full Text] [Related]
12. Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia.
Drach J; Gattringer C; Huber H
Br J Haematol; 1991 Jan; 77(1):37-42. PubMed ID: 1998595
[TBL] [Abstract][Full Text] [Related]
13. Double fluorochrome analysis of human bone marrow lymphoid cells: studies with terminal transferase and anti-T-cell monoclonal antibodies.
Neudorf SM; Le Bien TW; Bollum F; Kersey JH
Exp Hematol; 1984 Jan; 12(1):69-73. PubMed ID: 6607843
[TBL] [Abstract][Full Text] [Related]
14. T-cell lymphoblastic lymphoma with subsequent acute nonlymphocytic leukemia: a case report.
Posner MR; Said J; Pinkus GS; Nadler LM; Hardy R; Flatow F; Skarin AT
Cancer; 1982 Jul; 50(1):118-24. PubMed ID: 6979379
[TBL] [Abstract][Full Text] [Related]
15. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
16. [Terminal deoxynucleotidyltransferase (TdT)-positive cells in cerebrospinal fluid of children with leukemia or non-Hodgkin lymphoma: implications for the diagnosis of central nervous system leukemia].
Hooijkaas H; Adriaansen HJ; Hählen K; van Zanen GE; van Dongen JJ
Tijdschr Kindergeneeskd; 1986 Apr; 54(2):46-50. PubMed ID: 3520947
[TBL] [Abstract][Full Text] [Related]
17. Terminal transferase in acute lymphoblast leukemia in remission.
Stass SA; McGraw TP; Folds JD; Odle B; Bollum FJ
Am J Clin Pathol; 1981 Jun; 75(6):838-40. PubMed ID: 7020402
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of p165 myeloid surface antigen and terminal deoxynucleotidyl transferase: a comparison of acute myeloid leukaemia and normal bone marrow cells.
Bradstock KF; Kerr A; Kabral A; Favaloro EJ; Hewson JW
Am J Hematol; 1986 Sep; 23(1):43-50. PubMed ID: 3526873
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies that recognize a broad range of mammalian terminal deoxynucleotidyl transferases.
Smith RG; Baumgarten B
Hybridoma; 1987 Feb; 6(1):29-45. PubMed ID: 2445652
[TBL] [Abstract][Full Text] [Related]
20. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
